Announcement PDF ASX:ARO ASX Announcement 23 October 2026 2026 NOTICE OF ANNUAL GENERAL MEETING Altoro Metals Limited (ASX:ARO) (“Altoro” or the “Company”) advises that its 2026 Annual General Meeting will be held at the offices of HLB Mann Judd, Level 5, 10 Shelley Street, Sydney NSW 2000 on Monday, 23 November 2026 at 1:30pm (AEDT). Attached are the Notice of Meeting, proxy form and a letter to shareholders setting out how to access the meeting documents. This announcement has been authorised for release by the Board of Altoro Metals Limited. ENDS Altoro Metals Limited Tony Wehby Chairman info@altorometals.com Media & Investor enquiries Jane Morgan Director jm@janemorganmanagement.com.au About Altoro Metals Limited Altoro Metals Limited is an ASX-listed exploration company focused on advancing a portfolio of zinc and polymetallic projects in Spain. The Company’s flagship Novales-Udías Project in Cantabria encompasses the former-producing San José underground mine and a broader mineralised district with substantial exploration potential. Altoro is also advancing the Guajaraz Zn-Pb-Ag-Cu Project in central Spain, where a maiden diamond drilling programme is planned to test priority targets within a historically mined but underexplored polymetallic system. With a strengthened balance sheet and active exploration programmes across both projects, Altoro is focused on defining and expanding high- quality base and critical metals opportunities in established European mining jurisdictions. ABN 16 003 254 395 ABN 16 003 254 395 23 October 2026 Dear Shareholder, Altoro Metals Limited (ASX:ARO) (the Company) advises that its 2026 Annual General Meeting of shareholders will be held at the offices of HLB Mann Judd, Level 5, 10 Shelley Street, Sydney NSW 2000 on Monday, 23 November 2026 at 1:30pm (AEDT) (the Meeting). In accordance with section 110D(1) of the Corporations Act 2001 (Cth), the Company will not be sending physical copies of the Notice of Meeting and accompanying Explanatory Statement (Meeting Materials) to shareholders unless they have made a valid election to receive documents in physical form. A copy of the Meeting Materials will be available electronically under the “Announcements” section of the Company’s website at https://altorometals.com/announcements or on the ASX website (https://www.asx.com.au) under the Company’s code ARO. As you have not elected to receive notices by email, a copy of your personalised proxy form is enclosed for your convenience. Shareholders are encouraged to complete and lodge their proxies online or otherwise in accordance with the instructions set out in the proxy form and the Notice of Meeting. Your proxy voting instruction must be received by 1:30pm (AEDT) on Saturday, 21 November 2026, being not less than 48 hours before the commencement of the Meeting. Any proxy voting instructions received after that time will not be valid for the Meeting. The Company intends to hold a physical meeting. The Company will notify you of any changes to this by way of an announcement on ASX and will also make details available on its website. The Notice of Meeting is important and should be read in its entirety. If you are in doubt as to the course of action you should follow, you should consult your financial adviser, lawyer, accountant or other professional adviser. If you have any difficulties obtaining a copy of the Notice of Meeting, please contact the Company’s share registry, Automic Group Pty Ltd, on 1300 288 664 (within Australia) or +61 2 9698 5414. Shareholders who wish to update their details to receive communications and notices electronically can do so by visiting the Company’s share registry website at https://investor.automic.com.au/. Sincerely, Mark Pitts Company Secretary Altoro Metals Limited ALTORO METALS LIMITED ACN 003 254 395 NOTICE OF ANNUAL GENERAL MEETING Level 5, 10 Shelley Street SYDNEY NSW 2000 The business of the Meeting affects your shareholding and your vote is important. This Notice should be read in its entirety. If Shareholders are in doubt as to how they should vote, they should seek advice from their professional advisers prior to voting. The Directors have determined pursuant to Regulation 7.11.37 of the Corporations Regulations 2001 (Cth) that the persons eligible to vote at the Meeting are those who are registered Shareholders at 1:30pm (AEDT) on 21 November 2026. Notice is given that the Meeting will be held at: TIME: 1:30pm (AEDT) DATE: 23 November 2026 PLACE: HLB Mann Judd 6694-01/8913430_5 1 B U S I N ES S OF TH E M EE T I N G FINANCIAL STATEMENTS AND REPORTS To receive and consider the annual financial report of the Company for the financial year ended 30 June 2026 together with the declaration of the Directors, the Director’s report, the Remuneration Report and the auditor’s report. 1. RESOLUTION 1 – ADOPTION OF REMUNERATION REPORT To consider and, if thought fit, to pass, with or without amendment, the following Resolution as a non-binding resolution: “That, for the purposes of section 250R(2) of the Corporations Act and for all other purposes, approval is given for the adoption of the Remuneration Report as contained in the Company’s annual financial report for the financial year ended 30 June 2026.” Note: the vote on this Resolution is advisory only and does not bind the Directors or the Company. 2. RESOLUTION 2 – ELECTION OF MR MYLES CAMPION To consider and, if thought fit, to pass, with or without amendment, the following Resolution as an ordinary resolution: “That, for the purposes of article 7.6(c) of the Constitution, Listing Rule 14.4 and for all other purposes, Mr Myles Campion, a Director appointed on 6 August 2026, retires, and being eligible, is elected as a Director.” 3. RESOLUTION 3 – APPROVAL OF 7.1A MANDATE To consider and, if thought fit, to pass the following Resolution as a special resolution: “That, for the purposes of Listing Rule 7.1A and for all other purposes, approval is given for the Company to issue up to that number of Equity Securities equal to 10% of the issued capital of the Company at the time of issue, calculated in accordance with the formula prescribed in Listing Rule 7.1A.2 and otherwise on the terms and conditions set out in the Explanatory Statement.” 4. RESOLUTION 4 – RATIFICATION OF PRIOR ISSUE OF FACILITY OPTIONS To consider and, if thought fit, to pass, with or without amendment, the following Resolution as an ordinary resolution: “That, for the purposes of Listing Rule 7.4 and for all other purposes, Shareholders ratify the issue of 13,125,000 Options on the terms and conditions set out in the Explanatory Statement.” A voting exclusion statement applies to this Resolution. Please see below. 5. RESOLUTION 5 – APPROVAL TO ISSUE FEE OPTIONS TO MR VAUGHAN (TOM) KENT IN LIEU OF DIRECTORS’ FEES To consider and, if thought fit, to pass, with or without amendment, the following Resolution as an ordinary resolution: “That, for the purposes of sections 195(4) and 208 of the Corporations Act, Listing Rule 10.11 and for all other purposes, approval is given for the Company to issue up to 8,333,333 zero exercise price options to Mr Vaughan (Tom) Kent (or his nominee) in lieu of directors’ fees for the period from 1 December 2026 to 30 November 2027, on the terms and conditions set out in the Explanatory Statement.” A voting exclusion statement and voting prohibition statement apply to this Resolution. Please see below. 6694-01/8913430_5 2 6. RESOLUTION 6 – APPROVAL TO ISSUE FEE OPTIONS TO MR ANTHONY WEHBY IN LIEU OF DIRECTORS’ FEES To consider and, if thought fit, to pass, with or without amendment, the following Resolution as an ordinary resolution: “That, for the purposes of sections 195(4) and 208 of the Corporations Act, Listing Rule 10.11 and for all other purposes, approval is given for the Company to issue up to 8,333,333 zero exercise price options to Mr Anthony Wehby (or his nominee) in lieu of directors’ fees for the period from 1 December 2026 to 30 November 2027, on the terms and conditions set out in the Explanatory Statement.” A voting exclusion statement and voting prohibition statement apply to this Resolution. Please see below. 7. RESOLUTION 7 – APPROVAL TO ISSUE FEE OPTIONS TO DR FRANK BIERLEIN IN LIEU OF DIRECTORS’ FEES To consider and, if thought fit, to pass, with or without amendment, the following Resolution as an ordinary resolution: “That, for the purposes of sections 195(4) and 208 of the Corporations Act, Listing Rule 10.11 and for all other purposes, approval is given for the Company to issue up to 8,333,333 zero exercise price options to Dr Frank Bierlein (or his nominee) in lieu of directors’ fees for the period from 1 December 2026 to 30 November 2027, on the terms and conditions set out in the Explanatory Statement.” A voting exclusion statement and voting prohibition statement apply to this Resolution. Please see below. 8. RESOLUTION 8 – APPROVAL TO ISSUE FEE OPTIONS TO MR MYLES CAMPION IN LIEU OF DIRECTORS’ FEES To consider and, if thought fit, to pass, with or without amendment, the following Resolution as an ordinary resolution: “That, for the purposes of sections 195(4) and 208 of the Corporations Act, Listing Rule 10.11 and for all other purposes, approval is given for the Company to issue up to 8,333,333 zero exercise price options to Mr Myles Campion (or his nominee) in lieu of directors’ fees for the period from 1 December 2026 to 30 November 2027, on the terms and conditions set out in the Explanatory Statement.” A voting exclusion statement and voting prohibition statement apply to this Resolution. Please see below. Dated: 14 October 2026 6694-01/8913430_5 3 Voting Prohibition Statements Resolution 1 – Adoption of Remuneration Report In accordance with sections 250(BD)(2) and 250R, a vote on this Resolution must not be cast: (a) by or on behalf of a member of the Key Management Personnel, details of whose remuneration are included in the Remuneration Report or a Closely Related Party of such a member, regardless of the capacity in which the vote is cast; or (b) as a proxy by a member of the Key Management Personnel at the date of the Meeting, or their Closely Related Parties. However, a person (the voter) described above may cast a vote on this Resolution as a proxy if the vote is not cast on behalf of a person described above and either: (a) the voter is appointed as a proxy by writing that specifies the way the proxy is to vote on this Resolution; or (b) the voter is the Chair and the appointment of the Chair as proxy: (i) does not specify the way the proxy is to vote on this Resolution; and (ii) expressly authorises the Chair to exercise the proxy even though this Resolution is connected directly or indirectly with the remuneration of a member of the Key Management Personnel. Resolution 5 – Approval to issue Fee Options to Mr Vaughan (Tom) Kent in lieu of directors’ fees A person appointed as a proxy must not vote, on the basis of that appointment, on this Resolution if: (a) the proxy is either: (i) a member of the Key Management Personnel; or (ii) a Closely Related Party of such a member; and (b) the appointment does not specify the way the proxy is to vote on this Resolution. However, the above prohibition does not apply if: (a) the proxy is the Chair; and (b) the appointment expressly authorises the Chair to exercise the proxy even though this Resolution is connected directly or indirectly with remuneration of a member of the Key Management Personnel. Resolution 6 – Approval to issue Fee Options to Mr Anthony Wehby in lieu of directors’ fees A person appointed as a proxy must not vote, on the basis of that appointment, on this Resolution if: (a) the proxy is either: (i) a member of the Key Management Personnel; or (ii) a Closely Related Party of such a member; and (b) the appointment does not specify the way the proxy is to vote on this Resolution. However, the above prohibition does not apply if: (a) the proxy is the Chair; and (b) the appointment expressly authorises the Chair to exercise the proxy even though this Resolution is connected directly or indirectly with remuneration of a member of the Key Management Personnel. Resolution 7 – Approval to issue Fee Options to Dr Frank Bierlein in lieu of directors’ fees A person appointed as a proxy must not vote, on the basis of that appointment, on this Resolution if: (a) the proxy is either: (i) a member of the Key Management Personnel; or (ii) a Closely Related Party of such a member; and (b) the appointment does not specify the way the proxy is to vote on this Resolution. However, the above prohibition does not apply if: (a) the proxy is the Chair; and (b) the appointment expressly authorises the Chair to exercise the proxy even though this Resolution is connected directly or indirectly with remuneration of a member of the Key Management Personnel. Resolution 8 – Approval to issue Fee Options to Mr Myles Campion in lieu of directors’ fees A person appointed as a proxy must not vote, on the basis of that appointment, on this Resolution if: (a) the proxy is either: (i) a member of the Key Management Personnel; or (ii) a Closely Related Party of such a member; and (b) the appointment does not specify the way the proxy is to vote on this Resolution. However, the above prohibition does not apply if: (a) the proxy is the Chair; and (b) the appointment expressly authorises the Chair to exercise the proxy even though this Resolution is connected directly or indirectly with remuneration of a member of the Key Management Personnel. In addition, in accordance with section 224 of the Corporations Act, a vote on each of Resolutions 5 to 8 must not be cast (in any capacity) by or on behalf of a related party of the Company to whom the Resolution would permit a financial benefit to be given, or an associate of such a related party. 6694-01/8913430_5 4 However, this prohibition does not apply to a vote cast by a person as proxy appointed by writing that specifies how the proxy is to vote on the Resolution, provided the vote is not cast on behalf of a related party or an associate of a related party. Voting Exclusion Statements In accordance with Listing Rule 14.11, the Company will disregard any votes cast in favour of the Resolution set out below by or on behalf of the following persons: Resolution 4 – Ratification of prior issue of Facility Options A person who participated in the issue or is a counterparty to the agreement being approved (namely, the Facility Participants) or an associate of that person or those persons. Resolution 5 – Approval to issue Fee Options to Mr Vaughan (Tom) Kent in lieu of directors’ fees Mr Vaughan (Tom) Kent (or his nominee) and any other person who will obtain a material benefit as a result of the issue of the securities (except a benefit solely by reason of being a holder of ordinary securities in the Company) or an associate of that person or those persons. Resolution 6 – Approval to issue Fee Options to Mr Anthony Wehby in lieu of directors’ fees Mr Anthony Wehby (or his nominee) and any other person who will obtain a material benefit as a result of the issue of the securities (except a benefit solely by reason of being a holder of ordinary securities in the Company) or an associate of that person or those persons. Resolution 7 – Approval to issue Fee Options to Dr Frank Bierlein in lieu of directors’ fees Dr Frank Bierlein (or his nominee) and any other person who will obtain a material benefit as a result of the issue of the securities (except a benefit solely by reason of being a holder of ordinary securities in the Company) or an associate of that person or those persons. Resolution 8 – Approval to issue Fee Options to Mr Myles Campion in lieu of directors’ fees Mr Myles Campion (or his nominee) and any other person who will obtain a material benefit as a result of the issue of the securities (except a benefit solely by reason of being a holder of ordinary securities in the Company) or an associate of that person or those persons. However, this does not apply to a vote cast in favour of the Resolution by: (a) a person as a proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with the directions given to the proxy or attorney to vote on the Resolution in that way; or (b) the Chair as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with a direction given to the Chair to vote on the Resolution as the Chair decides; or (c) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met: (i) the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an associate of a person excluded from voting, on the Resolution; and (ii) the holder votes on the Resolution in accordance with directions given by the beneficiary to the holder to vote in that way. 6694-01/8913430_5 5 Voting by proxy To vote by proxy, please complete and sign the enclosed Proxy Form and return by the time and in accordance with the instructions set out on the Proxy Form. In accordance with section 249L of the Corporations Act, Shareholders are advised that: • each Shareholder has a right to appoint a proxy; • the proxy need not be a Shareholder of the Company; and • a Shareholder who is entitled to cast two or more votes may appoint two proxies and may specify the proportion or number of votes each proxy is appointed to exercise. If the Shareholder appoints two proxies and the appointment does not specify the proportion or number of the member’s votes, then in accordance with section 249X(3) of the Corporations Act, each proxy may exercise one-half of the votes. Shareholders and their proxies should be aware that: • if proxy holders vote, they must cast all directed proxies as directed; and • any directed proxies which are not voted will automatically default to the Chair, who must vote the proxies as directed. Voting in person To vote in person, attend the Meeting at the time, date and place set out above. Should you wish to discuss the matters in this Notice please do not hesitate to contact the Company Secretary on 1300 288 664. 6694-01/8913430_5 6 E X PL A N A T O R Y S T A T EM E N T This Explanatory Statement has been prepared to provide information which the Directors believe to be material to Shareholders in deciding whether or not to pass the Resolutions. 1. FINANCIAL STATEMENTS AND REPORTS In accordance with the Corporations Act, the business of the Meeting will include receipt and consideration of the annual financial report of the Company for the financial year ended 30 June 2026 together with the declaration of the Directors, the Directors’ report, the Remuneration Report and the auditor’s report. The Company will not provide a hard copy of the Company’s annual financial report to Shareholders unless specifically requested to do so. The Company’s annual financial report is available on its website at www.altorometals.com. 2. RESOLUTION 1 – ADOPTION OF REMUNERATION REPORT 2.1 General The Corporations Act requires that at a listed company’s annual general meeting, a Resolution that the remuneration report to be adopted must be put to the shareholders. However, such a Resolution is advisory only and does not bind the company or the directors of the company. The remuneration report sets out the company’s remuneration arrangements for the directors and senior management of the company. The remuneration report is part of the directors’ report contained in the annual financial report of the company for a financial year. The chair of the meeting must allow a reasonable opportunity for its shareholders to ask questions about or make comments on the remuneration report at the annual general meeting. 2.2 Voting consequences A company is required to put to its shareholders a Resolution proposing the calling of another meeting of shareholders to consider the appointment of directors of the company (Spill Resolution) if, at consecutive annual general meetings, at least 25% of the votes cast on a remuneration report Resolution are voted against adoption of the remuneration report and at the first of those annual general meetings a Spill Resolution was not put to vote. If required, the Spill Resolution must be put to vote at the second of those annual general meetings. If more than 50% of votes cast are in favour of the Spill Resolution, the company must convene a shareholder meeting (Spill Meeting) within 90 days of the second annual general meeting. All of the directors of the company who were in office when the directors' report (as included in the company’s annual financial report for the most recent financial year) was approved, other than the managing director of the company, will cease to hold office immediately before the end of the Spill Meeting but may stand for re-election at the Spill Meeting. Following the Spill Meeting those persons whose election or re-election as directors of the company is approved will be the directors of the company. 2.3 Previous voting results At the Company’s previous annual general meeting the votes cast against the remuneration report considered at that annual general meeting were less than 25%. Accordingly, the Spill Resolution is not relevant for this Meeting. 6694-01/8913430_5 7 3. RESOLUTION 2 – ELECTION OF MR MYLES CAMPION 3.1 General Article 7.6(a) of the Constitution allows the Directors to appoint at any time a person to be a Director, either to fill a casual vacancy or as an addition to the existing Directors. Under article 7.6(c) of the Constitution and Listing Rule 14.4, a Director so appointed holds office until the conclusion of the next annual general meeting and is eligible for election at that meeting. Mr Myles Campion, having been appointed as a Director on 6 August 2026 and being eligible, retires and seeks election. Listing Rule 14.5 and article 7.2(b) of the Constitution require an election of Directors to be held at each annual general meeting. Article 7.2(b)(ii) provides that this requirement is satisfied by a Director appointed under article 7.6 standing for election. Accordingly, no other Director is required to retire at this Meeting. Further information in relation to Mr Myles Campion is set out below. Qualifications, experience and other material directorships Mr Campion has more than 35 years of experience across the natural resources sector, having held senior roles spanning mineral exploration, resource analysis, fund management, equities research and project and debt financing. His career combines technical expertise with capital markets knowledge. Mr Campion has extensive knowledge of the European zinc sector through his long-standing involvement with the Toral Zinc Project in León in northern Spain, which lies approximately 150 kilometres from the Company’s Novales-Udías Project within the same metallogenic belt, and brings an understanding of the regional geology, the permitting framework and the operating environment. Mr Campion holds a Graduate Diploma of Business (Finance), an M.Sc. in Minerals Exploration from the Royal School of Mines in London and a B.Sc. Honours in Geology from the University of Wales College Cardiff. Mr Campion is a non-executive director of Tusker Minerals Ltd. Term of office Mr Myles Campion has served as a Director since 6 August 2026. The Company undertook appropriate checks into Mr Campion’s background and experience before his appointment, and those checks did not identify any information of concern. Independence If elected, the Board considers that Mr Myles Campion will be an independent Director. Board recommendation Having received an acknowledgement from Mr Myles Campion that he will have sufficient time to fulfil his responsibilities as a Director and having reviewed the skills, knowledge, experience and capabilities required by the Board, the Directors (other than Mr Myles Campion) recommend that Shareholders vote in favour of this Resolution. 3.2 Technical information required by Listing Rule 14.1A If this Resolution is passed, Mr Myles Campion will be elected to the Board as an independent Director. If this Resolution is not passed, Mr Myles Campion will cease to be a Director at the conclusion of the Meeting. The Company may seek nominations or otherwise identify suitably qualified candidates to join the Board. 6694-01/8913430_5 8 4. RESOLUTION 3 – APPROVAL OF 7.1A MANDATE 4.1 General This Resolution seeks Shareholder approval by way of special Resolution for the Company to have the additional 10% placement capacity provided for in Listing Rule 7.1A to issue Equity Securities without Shareholder approval. Broadly speaking, and subject to a number of exceptions, Listing Rule 7.1 limits the amount of equity securities that a listed company can issue without the approval of its shareholders over any 12 month period to 15% of the fully paid ordinary shares it had on issue at the start of that period. Under Listing Rule 7.1A, an Eligible Entity may seek shareholder approval by way of a special Resolution passed at its annual general meeting to increase this 15% limit by an extra 10% to 25% (7.1A Mandate). An Eligible Entity means an entity which is not included in the S&P/ASX 300 Index and has a market capitalisation of $300,000,000 or less. As of the date of this Notice, the Company’s market capitalisation is $8,801,822. The Company is therefore an Eligible Entity. 4.2 Technical information required by Listing Rule 14.1A For this Resolution to be passed, at least 75% of votes cast by Shareholders present and eligible to vote at the Meeting must be cast in favour of the Resolution. If this Resolution is passed, the Company will be able to issue Equity Securities up to the combined 25% limit in Listing Rules 7.1 and 7.1A without any further Shareholder approval. If this Resolution is not passed, the Company will not be able to access the additional 10% capacity to issue Equity Securities without Shareholder approval under Listing Rule 7.1A and will remain subject to the 15% limit on issuing Equity Securities without Shareholder approval set out in Listing Rule 7.1. 4.3 Technical information required by Listing Rule 7.3A REQUIRED INFORMATION DETAILS Period for which the 7.1A Mandate is valid The 7.1A Mandate will commence on the date of the Meeting and expire on the first to occur of the following: (a) the date that is 12 months after the date of this Meeting; (b) the time and date of the Company’s next annual general meeting; and (c) the time and date of approval by Shareholders of any transaction under Listing Rule 11.1.2 (a significant change in the nature or scale of activities) or Listing Rule 11.2 (disposal of the main undertaking). Minimum price Any Equity Securities issued under the 7.1A Mandate must be in an existing quoted class of Equity Securities and be issued for cash consideration at a minimum price of 75% of the volume weighted average price of Equity Securities in that class, calculated over the 15 trading days on which trades in that class were recorded immediately before: (a) the date on which the price at which the Equity Securities are to be issued is agreed by the entity and the recipient of the Equity Securities; or (b) if the Equity Securities are not issued within 10 trading days of the date in paragraph (a) above, the date on which the Equity Securities are issued. 6694-01/8913430_5 9 REQUIRED INFORMATION DETAILS Use of funds The Company intends to use funds raised from issues of Equity Securities under the 7.1A Mandate for continued investment in the Company's current assets, the acquisition of new assets or investments (including expenses associated with such an acquisition), and/or for general working capital. Risk of economic and voting dilution Any issue of Equity Securities under the 7.1A Mandate will dilute the interests of Shareholders who do not receive any Shares under the issue. If this Resolution is approved by Shareholders and the Company issues the maximum number of Equity Securities available under the 7.1A Mandate, the economic and voting dilution of existing Shares would be as shown in the table below. The table below shows the dilution of existing Shareholders calculated in accordance with the formula outlined in Listing Rule 7.1A.2, on the basis of the closing market price of Shares and the number of Equity Securities on issue or proposed to be issued as at 14 October 2026. The table also shows the voting dilution impact where the number of Shares on issue (Variable A in the formula) changes and the economic dilution where there are changes in the issue price of Shares issued under the 7.1A Mandate. DILUTION Number of Shares on Issue (Variable A in Listing Rule 7.1A.2) Shares issued – 10% voting dilution Issue Price $0.00175 $0.0035 $0.00525 50% decrease Issue Price 50% increase Funds Raised Current 2,514,806,384 251,480,638 $440,091 $880,182 $1,320,273 50% increase 3,772,209,576 377,220,957 $660,137 $1,320,273 $1,980,410 100% increase 5,029,612,768 502,961,276 $880,182 $1,760,364 $2,640,547 *The number of Shares on issue (Variable A in the formula) could increase as a result of the issue of Shares that do not require Shareholder approval (such as under a pro-rata rights issue or scrip issued under a takeover offer) or that are issued with Shareholder approval under Listing Rule 7.1. The table above uses the following assumptions: 1. There are currently 2,514,806,384 Shares on issue as at the date of this Notice. This does not include any Shares which may be issued if Resolutions 5 to 8 are passed at this Meeting. 2. The issue price set out above is the closing market price of the Shares on the ASX on 14 October 2026 (being $0.0035) (Issue Price). 3. The Company issues the maximum possible number of Equity Securities under the 7.1A Mandate. 4. Other than the 13,125,000 Facility Op